RareSearch logo

Seattle Children's Hospital Research Institute - Center for Global Infectious Disease Research

50+ personnel
Headquartered in Chandler
Established in 2026
Website
Maggie Anderson profile

Maggie Anderson

🇮🇹 Italy

6

    Reviewed:

  • - Health Technology Assessment
  • - 8 weeks July - September 2024
  • - Pharmaceutical Company

Health technology assessment was superficial, lacked thorough analysis.

The health technology assessment (HTA) was superficial and did not provide the level of thorough analysis we needed. Some important factors were overlooked, and we had to request additional work to cover these gaps. The overall experience was disappointing.

Flora Bernier Sr. profile

Flora Bernier Sr.

🇬🇧 United Kingdom

8.9

    Reviewed:

  • - Regulatory Submission
  • - 6 weeks February 2023
  • - Biotech Startup

Professional and knowledgeable, seamless regulatory submission process.

Our regulatory submission was handled with great care and expertise. The process was seamless, and their knowledge of the regulatory landscape was impressive. The team's support was invaluable, and I would not hesitate to use their services again.

Greg Bruen profile

Greg Bruen

🇸🇦 Saudi Arabia

9.1

    Reviewed:

  • - HTA Submission
  • - 8 weeks February - March 2024
  • - Biotech Company

Comprehensive and well-executed HTA submission.

The HTA submission was comprehensive and well-executed. The team managed the complexities of the submission process expertly, ensuring that all necessary data was included and well-presented.

Edwin Oberbrunner profile

Edwin Oberbrunner

🇳🇱 Netherlands

9.1

    Reviewed:

  • - Clinical Data Management
  • - 6 weeks June - July 2023
  • - CRO

Timely and accurate data management, great collaboration.

The data management services were delivered on time and with great accuracy. Collaboration with the team was smooth, and they were always available to address any concerns or questions we had. We were very satisfied with the outcome.

Jacob Schultz profile

Jacob Schultz

🇮🇩 Indonesia

6.2

    Reviewed:

  • - Clinical Protocol Design
  • - 10 weeks January - March 2024
  • - Pharmaceutical Company

Inconsistent quality of deliverables, frequent revisions needed.

The protocol design process required multiple revisions due to inconsistencies in the deliverables. Although the team was responsive to feedback, the back-and-forth extended the timeline beyond what was originally agreed upon.

Miss Whitney Hartmann profile

Miss Whitney Hartmann

🇮🇩 Indonesia

8.6

    Reviewed:

  • - Patient Engagement
  • - 8 weeks August - September 2023
  • - Clinical Research Organization

Impressive patient engagement strategies, significant improvement in recruitment rates.

The patient engagement strategies implemented were impressive and led to a significant improvement in our recruitment rates. The team's experience in patient-centered approaches was evident and made a real difference.